Poland· PL-100232983
Ivineb
A nebivolol product containing nebivololum, registered in Poland by Bioton S.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nebivolol is registered in 16 of 19 countries.
Countries holding a registration under ATC C07AB12 (nebivolol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Nebivolol · ATC C07AB12
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nebivolol costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.092 in United States to $0.39 in Switzerland — a ×4.2 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Nebivolol · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.39
- ES Spain$0.32
- IT Italy$0.25
- FR France$0.14
- US United States$0.092 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Nebivololum
- Manufacturer
- Bioton S.A.
- Country
- Poland (PL)
- ATC code
- C07AB12
- ATC class
- Nebivolol
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 12
1 priced- gtin05909990805457
- gtin05909990805464
- gtin05909990805471
- gtin05909990805488
- gtin0590999080549528 szt.PLN 12.17
- gtin05909990805501
- gtin05909990805525
- gtin05909990805532
- gtin05909990805549
- gtin05909990805556
- gtin05909990805563
- gtin05909990805570
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for nebivolol.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nebivolol · interactions on record
273 records
- 10 severe
- 202 moderate
- 17 minor
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
44 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nebivolol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEBILETBERLIN-CHEMIE AG, Berlín
- United KingdomHypoloc 5mg tabletsA. Menarini Farmaceutica Internazionale SRL
- United StatesBystolicAllergan, Inc.
- SpainINSUCOR 5 MG COMPRIMIDOS EFGGlenmark Arzneimittel Gmbh
- ItalyLOBIVONGMM FARMA S.R.L.
- FranceNEBILOX 5 mg, comprimé quadrisécableMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- SwitzerlandNebilet, TablettenA. Menarini GmbH
- NetherlandsHypoloc tabletten 5 mgMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Nebilan, Nebivolol +pharma
- Belgium · Nebivolol Ab, Nebivolol Eg
- Bulgaria · Nebilan, Nebivolol Sandoz
- Cyprus · Lobivon, Nebivolol Accord
- Czechia · Nebilet, Nebivolol Medreg
- Germany · Nebilet, Nebivolol 089pharm
- Denmark · Hypoloc, Nebivolol Accord
- Estonia · Nebicard, Nebilet
- Spain · Insucor, Lobivon
- Finland · Hypoloc, Nebivolol Accord
- France · Nebilox, Nebivolol Almus
- United Kingdom (Northern Ireland) · Nebilet, Nebivolol
- Greece · Bivol, Hypoloc
- Croatia · Massido, Nebilet
- Hungary · Nebibeta, Nebilet
- Ireland · Nebilet, Nebimel
- Italy · Lobivon, Nebilox
- Lithuania · Nebicard, Nebilet
- Luxembourg · Nebivolol Eg, Nobiten
- Latvia · Nebilet, Nebivolol Actavis
- Malta · Nebilet, Nebivolol Atb
- Netherlands · Hypoloc, Lobivon
- Portugal · Nebilet, Nebivolol Aurovitas
- Romania · Nebilet, Nebivolol Gemax Pharma
- Slovenia · Nebilet, Nebivolol Krka
- Slovakia · Nebilet, Nebitrix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4df5a5b-c858-4084-943c-6cf0542c5dca GET /v1/drugs/e4df5a5b-c858-4084-943c-6cf0542c5dca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909990805457 ¦ Rp ¦ 60577\n7 tabl.\n05909990805464 ¦ Rp ¦ 60578\n10 tabl.\n05909990805471 ¦ Rp ¦ 60579\n14 tabl.\n05909990805488 ¦ Rp ¦ 60580\n20 tabl.\n05909990805495 ¦ Rp ¦ 60581\n28 tabl.\n05909990805501 ¦ Rp ¦ 60582\n30 tabl.\n05909990805525 ¦ Rp ¦ 60583\n50 tabl.\n05909990805532 ¦ Rp ¦ 60584\n56 tabl.\n05909990805549 ¦ Rp ¦ 60585\n60 tabl.\n05909990805556 ¦ Rp ¦ 60586\n90 tabl.\n05909990805563 ¦ Rp ¦ 60587\n100 tabl.\n05909990805570 ¦ Rp ¦ 60588\n120 tabl.",
"substance": "Nebivololi hydrochloridum 5.45 mg",
"common_name": "Nebivololum",
"pl_product_id": "100232983",
"pozwolenie_nr": "17140",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about nebivolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.